journal article·2016-07-02

Thermosensitive injectable hydrogels from poly(N-isopropylacrylamide)–dextran aqueous solutions: Thermogelation and drug release properties

Maria Andrei, Gabriel Turturica, Paul O. Stanescu, Mircea Teodorescu

Soft Materials· Volume 14· Issue 3
Publisher page

Abstract

Novel injectable thermosensitive hydrogel formulations with improved both water retention (WR) and drug release profile were prepared by adding dextran (DXT) to poly(N-isopropylacrylamide) (PNIPAM) aqueous solutions as a remedy against the demixing/syneresis phenomenon. The addition of the hydrophilic polysaccharide improved the WR of the hydrogel at 37°C from about 12% in the absence of DXT to about 40–55% out of the initial amount introduced, depending on both PNIPAM and DXT concentrations. Also, the 5-fluorouracil release experiments showed an appreciably reduced “burst effect” for the DXT-containing hydrogels. The shape of the release profiles revealed the presence of two stages, differing each other from the point of view of the drug release rate.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Advanced Materials and Mechanics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioresources and Polymer Science, Faculty of Applied Chemistry and Materials Science, Polytechnic University of Bucharest, Bucharest, Romania

Funding

The Ministry of National Education, CNCS – UEFISCDI

References (42)

Show source-provided references
1. 10.1016/j.ejpb.2004.03.01910.1016/j.ejpb.2004.03.019 ↗
2. 10.1016/j.ijpharm.2008.01.05710.1016/j.ijpharm.2008.01.057 ↗
3. 10.1517/17425247.2011.58165610.1517/17425247.2011.581656 ↗
4. 10.1021/ma201261m10.1021/ma201261m ↗
5. 10.1002/polb.2308110.1002/polb.23081 ↗
6. 10.1016/j.progpolymsci.2012.08.00210.1016/j.progpolymsci.2012.08.002 ↗
7. 10.1016/j.progpolymsci.2014.07.00610.1016/j.progpolymsci.2014.07.006 ↗
8. 10.1016/j.msec.2014.04.02610.1016/j.msec.2014.04.026 ↗
9. 10.1016/j.jconrel.2014.04.05610.1016/j.jconrel.2014.04.056 ↗
10. 10.1166/jbn.2015.196210.1166/jbn.2015.1962 ↗
11. 10.1016/S0169-409X(01)00242-310.1016/S0169-409X(01)00242-3 ↗
12. 10.1039/b406727d10.1039/b406727d ↗
13. Schmaljohann D. · Advanced Drug Delivery Reviews · 1655 · 58
14. 10.1007/s00396-009-2028-x10.1007/s00396-009-2028-x ↗
15. 10.1166/jbn.2015.207310.1166/jbn.2015.2073 ↗
16. 10.1039/C5TB01399B10.1039/C5TB01399B ↗
17. 10.1016/0079-6700(92)90023-R10.1016/0079-6700(92)90023-R ↗
18. 10.1021/ja065324n10.1021/ja065324n ↗
19. 10.1016/S0032-3861(97)00612-510.1016/S0032-3861(97)00612-5 ↗
20. 10.1021/ma047393x10.1021/ma047393x ↗
21. 10.1016/j.reactfunctpolym.2010.07.01510.1016/j.reactfunctpolym.2010.07.015 ↗
22. 10.1007/s00396-013-2994-x10.1007/s00396-013-2994-x ↗
23. 10.1080/1539445X.2011.59781610.1080/1539445X.2011.597816 ↗
24. 10.1021/bm300429e10.1021/bm300429e ↗
25. 10.1016/j.biomaterials.2006.08.01210.1016/j.biomaterials.2006.08.012 ↗
26. 10.1021/ma991809310.1021/ma9918093 ↗
27. 10.1080/1539445X.2011.64073110.1080/1539445X.2011.640731 ↗
28. 10.1080/00914037.2015.103064610.1080/00914037.2015.1030646 ↗
29. 10.1002/mabi.20039001410.1002/mabi.200390014 ↗
30. 10.1002/macp.20050012510.1002/macp.200500125 ↗
31. Metters A.T. · 2007
32. 10.1016/j.ijbiomac.2013.07.00210.1016/j.ijbiomac.2013.07.002 ↗
33. 10.1002/mabi.20060016410.1002/mabi.200600164 ↗
34. 10.1002/1521-3927(20020401)23:7<407::AID-MARC407>3.0.CO;2-710.1002/1521-3927(20020401)23:7<407::AID-MARC407>3.0.CO;2-7 ↗
35. 10.1002/marc.20030027910.1002/marc.200300279 ↗
36. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
37. 10.1016/j.eurpolymj.2014.09.01110.1016/j.eurpolymj.2014.09.011 ↗
38. 10.1021/ma001852m10.1021/ma001852m ↗
39. 10.1021/bm060253610.1021/bm0602536 ↗
40. 10.1039/b102819g10.1039/b102819g ↗
41. 10.1080/01932691.2010.49770110.1080/01932691.2010.497701 ↗
42. 10.1016/j.msec.2012.12.03010.1016/j.msec.2012.12.030 ↗